Canandaigua National Corp Amgen Inc Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Amgen Inc stock. As of the latest transaction made, Canandaigua National Corp holds 13,682 shares of AMGN stock, worth $4.21 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

13,682

Previous 12,928 5.83%

Holding current value

$4.21 Million

Previous $2.91 Million 23.3%

% of portfolio

0.61%

Previous 0.52%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $172,688 - $219,421	754 Added 5.83%	13,682 $3.59 Million
Q3 2022 Oct 05, 2022	BUY	$224.46 - $253.15 $145,001 - $163,534	646 Added 5.26%	12,928 $2.91 Million
Q2 2022 Jul 05, 2022	SELL	$230.71 - $256.74 $66,675 - $74,197	-289 Reduced 2.3%	12,282 $2.99 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $399,948 - $442,447	1,824 Added 16.97%	12,571 $3.04 Million
Q4 2021 Jan 04, 2022	BUY	$198.88 - $227.6 $44,946 - $51,437	226 Added 2.15%	10,747 $2.42 Million
Q3 2021 Oct 04, 2021	SELL	$212.27 - $248.7 $46,699 - $54,714	-220 Reduced 2.05%	10,521 $2.24 Million
Q2 2021 Jul 06, 2021	BUY	$233.58 - $259.14 $43,679 - $48,459	187 Added 1.77%	10,741 $2.62 Million
Q1 2021 Apr 05, 2021	SELL	$221.91 - $258.6 $443 - $517	-2 Reduced 0.02%	10,554 $2.63 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $23,801 - $28,343	110 Added 1.05%	10,556 $2.43 Million
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $510,129 - $567,305	-2,174 Reduced 17.23%	10,446 $2.66 Million
Q2 2020 Jul 07, 2020	BUY	$197.81 - $242.74 $2.5 Million - $3.06 Million	12,620 New	12,620 $2.98 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Amgen Inc Transaction History